Exchange: OTC·Updated 03:59 PM EDT

ALPMY ASTELLAS PHARMA/ADR

$15.05
$0.42
(2.71%)
Today
EarningsOct 29
Mkt Cap$26.98B
Vol76,049.00

About ALPMY

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
40

Bearish Sentiment

How do you feel about ALPMY?

Advertisement|Remove ads.